-
301
Gene Regulatory Network of Human GM-CSF-Secreting T Helper Cells
Published 2021-01-01“…GM-CSF produced by autoreactive CD4-positive T helper cells is involved in the pathogenesis of autoimmune diseases, such as multiple sclerosis. However, the molecular regulators that establish and maintain the features of GM-CSF-positive CD4 T cells are unknown. …”
Get full text
Article -
302
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments
Published 2014-01-01“…The plasma levels of IL-17 and IL-22 in GBS and relapsing-remitting multiple sclerosis at the acute phase of relapse were also markedly elevated. …”
Get full text
Article -
303
Ocrelizumab-Induced Severe Colitis
Published 2020-01-01“…We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy. …”
Get full text
Article -
304
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas
Published 2013-01-01“…Matrix metalloproteinases (MMPs) are involved in the pathogenesis of neuroinflammatory diseases (such as multiple sclerosis) as well as in the expansion of malignant gliomas because they facilitate penetration of anatomical barriers (such as the glia limitans) and migration within the neuropil. …”
Get full text
Article -
305
miRNAs Participate in MS Pathological Processes and Its Therapeutic Response
Published 2016-01-01“…Multiple sclerosis is the most common autoimmune disease of the central nervous system. …”
Get full text
Article -
306
Detecting Demyelination by PET: The Lesion as Imaging Target
Published 2018-07-01“…In Brugarolas et al’s study 1 , we describe the development of the first PET tracer for voltage-gated K + channels based on a clinically approved drug for multiple sclerosis that can be used for imaging demyelination in animal models.…”
Get full text
Article -
307
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study
Published 2025-02-01“…Objectives: To examine long-term efficacy and safety of alemtuzumab in participants with multiple sclerosis (MS) and highly active disease (HAD) by combining up to 13 years of TOPAZ data and TREAT-MS interim data. …”
Get full text
Article -
308
Fenofibrate Inhibited the Differentiation of T Helper 17 Cells In Vitro
Published 2012-01-01“…Uncontrolled activity of T cells mediates autoimmune and inflammatory diseases such as multiple sclerosis, inflammatory bowel diseases, rheumatoid arthritis, type 1 diabetes, and atherosclerosis. …”
Get full text
Article -
309
Parry–Romberg Syndrome with Uhthoff’s Phenomena: A Spectrum of Autoimmune Disease?
Published 2019-01-01“…The present case suggests that PRS may possibly have an autoimmune etiology resembling that of multiple sclerosis.…”
Get full text
Article -
310
Role of Microglia in CNS Autoimmunity
Published 2013-01-01“…Multiple sclerosis (MS) is the most common autoimmune disease of the central nervous system (CNS) in the Western world. …”
Get full text
Article -
311
The Bioactivities of Phycocyanobilin from Spirulina
Published 2022-01-01“…Due to the above biological activities of phycocyanobilin PCB, it is expected to become a new effective drug for treating various diseases, such as COVID-19 complications, atherosclerosis, multiple sclerosis (MS), and ischaemic stroke (IS).…”
Get full text
Article -
312
Bidirectional Mendelian Randomization Analysis of the Association Between Mitochondrial Proteins and Neurodegenerative Diseases
Published 2025-01-01“…Conversely, analyses indicated significant associations of neurodegenerative diseases with mitochondrial protein gene variants, notably with AD, dementia with Lewy bodies, and multiple sclerosis, affecting multiple mitochondrial protein levels. …”
Get full text
Article -
313
Cellular Imaging at 1.5 T: Detecting Cells in Neuroinflammation using Active Labeling with Superparamagnetic Iron Oxide
Published 2004-04-01“…The ability to visualize cell infiltration in experimental autoimmune encephalomyelitis (EAE), a well-known animal model for multiple sclerosis in humans, was investigated using a clinical 1.5-T magnetic resonance imaging (MRI) scanner, a custom-built, high-strength gradient coil insert, a 3-D fast imaging employing steady-state acquisition (FIESTA) imaging sequence and a superparamagnetic iron oxide (SPIO) contrast agent. …”
Get full text
Article -
314
The Role of Decorin in Autoimmune and Inflammatory Diseases
Published 2022-01-01“…This review summarizes the characteristics of decorin in immune and inflammatory diseases, including inflammatory bowel disease (IBD), Sjögren’s syndrome (SS), chronic obstructive pulmonary disease (COPD), IgA nephropathy, rheumatoid arthritis (RA), spondyloarthritis (SpA), osteoarthritis, multiple sclerosis (MS), idiopathic inflammatory myopathies (IIM), and systemic sclerosis (SSc) and discusses the potential role in these disorders.…”
Get full text
Article -
315
Type 2 Inflammatory Responses in Autoimmune Demyelination of the Central Nervous System: Recent Advances
Published 2019-01-01“…Next-generation sequencing of CD4+ T cells isolated from a specific subtype of multiple sclerosis plaque has uncovered an unexpectedly Th2 profile of these cells. …”
Get full text
Article -
316
Therapeutic Application of rTMS in Atypical Parkinsonian Disorders
Published 2021-01-01Get full text
Article -
317
Adalimumab Induced or Provoked MS in Patient with Autoimmune Uveitis: A Case Report and Review of the Literature
Published 2016-01-01“…A 23-year-old male with autoimmune uveitis and a family history of multiple sclerosis (MS) developed two neurological attacks, after Adalimumab infusion, simultaneously with several cerebral lesions on magnetic resonance imaging (MRI). …”
Get full text
Article -
318
PPAR Regulation of Inflammatory Signaling in CNS Diseases
Published 2008-01-01“…Specific ligands for PPAR𝛼, 𝛾, and 𝛿 isoforms have proven effective in the animal models of multiple sclerosis (MS), Alzheimer's disease, Parkinson's disease, and trauma/stroke, suggesting their use in the treatment of neuroinflammatory diseases. …”
Get full text
Article -
319
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
Published 2015-01-01“…Mechanistically, PDE5-Is produce an anti-inflammatory and neuroprotection effect by increasing expression of nitric oxide synthases and accumulation of cGMP and activating protein kinase G (PKG), the signaling pathway of which is thought to play an important role in the development of several neurodiseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS). The aim of this paper was to review present knowledge of the signaling pathways that underlie the use of PDE5-Is in neuroinflammation, neurogenesis, learning, and memory.…”
Get full text
Article -
320
White Matter Injury in Central Nervous System Disorders
Published 2025-01-01“…In this article, we will briefly describe the structure and function of white matter, summarize the pathological changes of WMI, and focus on the molecular mechanisms and therapeutic research advances in WMI after ischemic stroke, cerebral hemorrhage, Alzheimer’s disease, and multiple sclerosis diseases.Keywords: white matter injury, central nervous system, oligodendrocytes, myelin…”
Get full text
Article